Literature DB >> 8329706

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor.

J Cermak1, N S Key, R R Bach, J Balla, H S Jacob, G M Vercellotti.   

Abstract

The acute inflammatory response is frequently accompanied by serious thrombotic events. We show that C-reactive protein (CRP), an acute-phase reactant that markedly increases its serum concentration in response to inflammatory stimuli, induced monocytes to express tissue factor (TF), a potent procoagulant. Purified human CRP in concentrations commonly achieved in vivo during inflammation (10 to 100 micrograms/mL) induced a 75-fold increase in TF procoagulant activity (PCA) of human peripheral blood mononuclear cells (PBM), with a parallel increase in TF antigen levels. CRP-induced PCA was completely blocked by a monoclonal antibody against human TF but not by irrelevant murine IgG. Dot blot analysis showed a significant increase of TF mRNA after 4 hours of incubation with CRP, followed by a peak of PCA within 6 and 8 hours. Actinomycin D and cycloheximide blocked CRP-stimulated PCA, suggesting that de novo TF protein synthesis was required. Endotoxin (LPS) contamination of CRP was excluded as the mediator of TF synthesis because: (1) CRP was Limulus assay negative; (2) induction of TF PCA by CRP was not blocked by Polymyxin B, in contrast to LPS-induced PCA; (3) antihuman CRP IgG inhibited CRP-induced PCA, but not LPS-induced PCA; (4) CRP was able to stimulate TF production in LPS-pretreated PBM refractory to additional LPS stimulation; and, (5) unlike LPS, CRP was incapable of inducing TF in human umbilical vein endothelial cells. We suggest that CRP-mediated TF production in monocytes may contribute to the development of disseminated intravascular coagulation and thrombosis in inflammatory states.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329706

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  137 in total

1.  Interleukin-10 regulates the tissue factor activity of monocytes in an in vitro model of bacterial endocarditis.

Authors:  M H Veltrop; J A Langermans; J Thompson; M J Bancsi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  The renaissance of C reactive protein.

Authors:  M B Pepys; A Berger
Journal:  BMJ       Date:  2001-01-06

Review 3.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 4.  Endothelial dysfunction and the metabolic syndrome.

Authors:  Gary E McVeigh; Jay N Cohn
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 5.  Inflammatory and oxidative markers in atherosclerosis: relationship to outcome.

Authors:  Mehdi H Shishehbor; Stanley L Hazen
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

6.  Effect of short-term aspirin use on C-reactive protein.

Authors:  D Feng; R P Tracy; I Lipinska; J Murillo; C McKenna; G H Tofler
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

7.  Microalbuminuria and C-reactive protein as a predictor of coronary artery disease in patients of acute chest pain.

Authors:  Smita Sharma; Veena Singh Ghalaut; Ramakant Dixit; Sanjeev Kumar; P Jacob George
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

8.  Relation between impaired antiplatelet response to clopidogrel and possible pleiotropic effects.

Authors:  Lukasz A Malek; Marcin Grabowski; Mateusz Spiewak; Krzysztof J Filipiak; Monika Szpotanska; Tomasz Imiela; Zenon Huczek; Dagna Bobilewicz; Grzegorz Opolski
Journal:  J Thromb Thrombolysis       Date:  2007-04-03       Impact factor: 2.300

Review 9.  Adjunct corticosteroid treatment in patients with pneumonia: A precision medicine approach.

Authors:  Srdjan Gavrilovic; Ana Andrijevic; Aida Mujakovic; Yewande Odeyemi; Belma Paralija; Ognjen Gajic
Journal:  Bosn J Basic Med Sci       Date:  2019-11-08       Impact factor: 3.363

10.  High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.

Authors:  Yacov Shacham; Eran Leshem-Rubinow; Arie Steinvil; Gad Keren; Arie Roth; Yaron Arbel
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.